Biotechnology

Mergers and Acquisitions Cancer Research Cancer Treatment Covid-19 Obesity Corporate Expansion Public Companies Genetic Disorders Neuromuscular Disorders Biotechnology Sector

Lotte Biologics Wins Manufacturing Deal to Produce Ottimo Pharma’s Jankistomig

The deal secures antibody drug supply at Syracuse Bio Campus to support Ottimo Pharma’s path to IND submission.

Sarepta Halts Elevidys Shipments for Non-Ambulatory Patients After Second Fatal Liver Failure

Wojcicki’s Nonprofit Tops Regeneron With $305M Bid for 23andMe

BioNTech to Acquire CureVac for $1.25 Billion to Drive mRNA Cancer Therapy

Samsung Biologics Announces Spin-Off of Biosimilar Unit to Form Samsung Epis Holdings

Novo Nordisk Partners with Septerna in $2.2 Billion Deal for Oral Obesity Therapies

Lotte Biologics Secures First ADC Manufacturing Deal, Launches Full-Scale Operations

Biogen Announces Move to New Headquarters in Kendall Common

Cargo Therapeutics Ceases Operations Following Clinical and Financial Setbacks

AstraZeneca Acquires Belgian Biotech EsoBiotec in $1 Billion Deal

Roche and Zealand Partner in $5.3 Billion Deal for Obesity Drug Development

23andMe Explores Strategic Options as Financial Struggles Deepen

Moderna Secures $590M U.S. Grant to Advance Bird Flu Vaccine Development